Zomedica (ZOMDF) Stock Statistics & Valuation Metrics

Zomedica has a market cap or net worth of $81.83M. The enterprise value is $55.59.

Zomedica has 979,949,650 shares outstanding. The number of shares has decreased by -2.65% in one year.

Zomedica’s return on equity (ROE) is -0.14 and return on invested capital (ROIC) is -12.41%.

The current PE Ratio of Zomedica is ―. Zomedica’s PEG ratio is ―.

In the last 12 months, Zomedica had revenue of 25.19M and earned -34.53M in profits. Earnings per share was -0.04.

In the last 12 months, operating cash flow was -23.83M and capital expenditures 4.19M, giving a free cash flow of -19.64M billion.

Zomedica pays an annual dividend of ―, resulting in a dividend yield of ―

Zomedica upcoming earnings date is Nov 5, 2026, TBA (Confirmed).

Zomedica as a current ratio of 11.06, with Debt / Equity ratio of 0.65%

In the past 12 months, Zomedica has paid -1.33M in taxes.

Zomedica EV to EBITDA ratio is -6.33, with an EV/FCF ratio of -9.02.

Zomedica has $76.88M in cash and marketable securities with $2.08M in debt, giving a net cash position of $74.80M billion.

Gross margin is 72.12%, with operating margin of -125.43%, and net profit margin of -137.10%.

The average price target for Zomedica is ―, which is 11.43% higher than the current price. The consensus rating is Moderate Buy